24% of US adults
say digestive health is the most important aspect of their overall health, per a 2022 IFIC survey on gut health and probiotics.
International Food Information Council, 2022Lactobacillus jensenii LBV116 is the lead active here, studied most for comfort after dairy. In the 154 mg (15 billion CFUs) Proprietary Probiotic Blend with four others, listed fifth. Lactobacillus rhamnosus GG is the most studied active here, with 11 human studies behind it, each one cited. Who it fits: made for women, adults.
Verified by IngredientMDThe panel on the left is the one we evaluated, line by line.
All 11 actives checked against the clinical evidence: dose, form, and what the research actually shows.
Doses, ratios, and how the ingredients work together. That assessment is the verdict above: "Backed by human trials".
The verdict is public and identical whether or not a brand pays. A formula that does not clear the bar gets nothing.
Read by the engine against 2.1 million data points from clinical trials, PubMed and more than a hundred vetted sources. No individual reviewer is named or implied.
Public health figures the engine matched to this formula's ingredients. Reported by their source, cited and dated, never written by the brand.
24% of US adults
say digestive health is the most important aspect of their overall health, per a 2022 IFIC survey on gut health and probiotics.
International Food Information Council, 202252% of US adults
believe common digestive symptoms such as bloating and abdominal pain are just a normal part of life, per a 2026 Harris Poll conducted for Oshi Health.
The Harris Poll for Oshi Health, 202657.6%
During 2017 to 2018, 57.6% of US adults aged 20 and over reported using a dietary supplement in the past 30 days.
CDC National Center for Health Statistics58% of the recommended fiber intake
was reached on average by US consumers, who ate 8.1 grams of fiber per 1,000 calories in 2017 to 2018 versus the 14 grams recommended, per USDA Economic Research Service analysis of federal food consumption survey data.
USDA Economic Research Service, 202340% of US adults
aged 18 and over report they experience bloating at least a few times a month, with 5% saying they experience it daily, per a 2023 Ipsos poll conducted for MDVIP.
Ipsos, 202334% of US adults
aged 18 and over report they experience abdominal discomfort or pain at least a few times per month, with women about twice as likely as men to report it several times weekly, per a 2023 Ipsos poll conducted for MDVIP.
Ipsos, 202328% of US adults
aged 18 and over say that digestive issues impact the quality of their life, a share that rises to about a third among those aged 18 to 44, per a 2023 Ipsos poll conducted for MDVIP.
Ipsos, 202332% of US adults
say they actively try to consume probiotics, and among them 60% try to do so at least once a day, per a 2022 IFIC survey on gut health.
International Food Information Council, 202259 to 66 days
was the median time it took adults to make a new daily health habit automatic across the studies a 2024 review pooled, with individuals ranging from 4 to 335 days.
Systematic review and meta-analysis, 202461% to 74%
About 61 to 74 percent of adults refilling a long-term medicine on their own stopped within a year, versus 33 to 44 percent on one set pickup day.
Cohort study, 2015Randomised trial, 2018
In adults carrying excess body weight, 12 weeks of L. gasseri BNR17 was followed by less visceral fat accumulation and a smaller waist circumference than placebo.
Journal of medicinal foodRandomised trial, 2026
Heat-killed Lactobacillus acidophilus IDCC 3302 improved measured skin hydration and wrinkle parameters compared with placebo over the supplementation period.
NutrientsRandomised trial, 2025
In a trial run around a marathon, probiotics shifted blood inflammation markers and self-reported sleep, a marker and a self-reported measure rather than a measured outcome.
NutrientsRandomised trial, 2025
Heat-sterilised L. crispatus KT-11 was associated with changes in T cell-related immune measures, which are laboratory markers of immune activity rather than clinical endpoints.
Nutrition ResearchMeta-analysis, 2026
An umbrella review of trials in athletes reported small and inconsistent changes in immune and inflammatory blood markers after probiotic supplementation.
PeerJRandomised trial, 2020
In a 4-week randomised, double-blind, placebo-controlled trial in 68 healthy adults, adding a bacteriophage blend containing LH01 to a Bifidobacterium animalis subsp. lactis probiotic showed a within-group improvement in a self-reported gut symptom score (p = 0.01) and a larger rise in Lactobacillus and short-chain fatty acid producing bacteria than the probiotic alone.
NutrientsRandomised trial, 2024
Reports glycaemic index, lipid panel and microbiome composition measures in adults supplemented with Lactobacillus rhamnosus. All three are laboratory markers rather than clinical outcomes.
FoodsMeta-analysis, 2026
Pooled trials in adults with excess body weight found probiotic supplementation gave small reductions in body weight and body mass index versus placebo.
Frontiers in public healthSystematic review, 2025
The review pools Lactobacillus supplementation trials in adults with excess body weight and reports modest changes in anthropometric measures with substantial heterogeneity between strains.
Narra JSystematic review, 2021
The review of probiotics and synbiotics in adults with overweight or excess body weight finds effects on weight measures that vary by strain and by study.
NutrientsSystematic review, 2026
A synthesis of postbiotic and metabiotic preparations on blood sugar markers in adults with high blood sugar. The endpoints are laboratory markers and LGG-derived material is one of several named inputs.
Frontiers in EndocrinologyRandomised trial, 2026
Evaluates a preparation containing Lactobacillus rhamnosus across clinical, biological and patient-reported measures in a single trial. The multidimensional design is the paper's contribution.
NutrientsRandomised trial, 2026
A study tested a byproduct of a bacteria strain, not the live organism, so findings apply to that processed material only.
BMC MicrobiologyRandomised trial, 2026
Oral L. crispatus M247 combined with vaginal laser therapy was assessed for clinical measures and vaginal microbiota composition. Microbiota shifts are community markers rather than clinical outcomes on their own.
Lasers in Medical ScienceMeta-analysis, 2026
A dose-response review found probiotic supplementation linked to a small average drop in blood cortisol, with the evidence graded low certainty.
BMC nutritionMeta-analysis, 2026
Pooling trials in healthy people, probiotic supplementation produced little to no detectable change in overall gut bacterial diversity, while some individual studies reported shifts in specific bacterial groups.
BMC medicineOpen-label trial, 2018
Eight weeks of LGG supplementation changed gut microbiota composition, while the imaging measure of intestinal inflammation did not show a detectable difference, which is a failure to detect a change rather than evidence of none.
Journal of Acquired Immune Deficiency SyndromesRandomised trial, 2022
A low glycaemic index energy-restricted diet changed faecal short-chain fatty acid concentrations, while adding Lactobacillus rhamnosus did not produce a detectable additional change. A failure to detect a difference, not evidence that none exists.
European Review for Medical and Pharmacological SciencesRandomised trial, 2021
In this single-blind placebo-controlled trial the authors did not detect a difference in weight loss between the probiotic and placebo arms, which is a failure to detect a difference rather than evidence that none exists.
Eating and Weight DisordersRandomised trial, 2026
A randomised trial of Lactobacillus acidophilus in infants assessed both crying behaviour and microbiota composition, with microbiota modulation reported as a co-primary measure alongside the behavioural outcome.
BMC PediatricsSystematic review, 2023
The review of synbiotic supplementation in children and adolescents with excess body weight reports inconsistent effects on anthropometric indices and body composition.
World Journal of PediatricsRandomised trial, 2026
A 12-month randomised trial measuring progression of early enamel lesions in children given a probiotic supplement.
European Journal of Oral SciencesRandomised trial, 2026
A randomised trial of early postoperative synbiotic supplementation, with Lactobacillus rhamnosus among the strains, reporting gastrointestinal tolerance measures after bariatric surgery.
Clinical NutritionRandomised trial, 2025
Oral probiotic Lactobacillus rhamnosus GG use in pregnancy was checked against maternal inflammation markers in a blinded trial, tracking markers rather than clinical outcomes.
American Journal of Reproductive ImmunologyRandomised trial, 2026
Reports executive function test scores in children given a probiotic supplement. Cognitive test scores are measures of performance on the task, and the report should be read at that level.
Neuropsychopharmacology ReportsPopulation figures from public health data. Context for the category, not a statement about any individual and not a claim about this product.
Each line below was derived from this formula's own record at the time of verification. Nothing here was written by the brand, and nothing can be added that the evidence does not carry.
9 ingredients, from each one's own page.
Community shifts are read by swab or sequencing over weeks rather than felt. Nobody has established a reliable sensation timeline for this one.
Most people notice digestive changes over one to two weeks. Immune related measures in trials are read after eight to twelve weeks of continuous use.
Digestive changes usually show over one to two weeks. Used alongside antibiotics, the relevant window is the course itself plus a week or two after.
Slow. Waist and body composition changes in the trials took around twelve weeks of daily use, so a tape measure reads this before you do.
Digestive changes usually appear within one to two weeks. A steadier bowel pattern generally settles around week three or four.
The four-phage blend it belongs to read changes in digestive comfort around weeks three to four. For this single phage on its own, nobody has measured a time course.
Phage activity shows up in stool bacterial counts rather than in sensation. The blend studies measured shifts across about 4 weeks, so a month of daily use is the honest window.
No same-day effect. Where the four-phage blend has been measured, changes in gut bacterial composition and comfort showed up across roughly four weeks.
Nothing acute. In the four-phage blend it belongs to, gut bacterial and comfort measures shifted over about four weeks of daily use.
How each ingredient usually behaves over time, from its own page on IngredientMD. General timing for the ingredient, not a measurement of this product.
It is a capsule, so the amount per serving is fixed and travels without measuring.
Where two of this brand's products carry actives the literature has read together, the pairing and its basis are below. The evidence word is the corpus row's own confidence, never a score.
Inulin passes human digestion intact and is fermented by lactic acid bacteria to lactate and short-chain fatty acids, lowering colonic pH. Strain plus substrate is the defining synbiotic pairing.
fermentable substrate for lactic acid bacteria. No combination trial has tested this exact pairing.
Inulin is a fermentable fructan that lactobacilli use as a carbon source, so it feeds the strain being delivered. This is the classic synbiotic pairing of a prebiotic fibre with an organism that can ferment it.
prebiotic substrate. No combination trial has tested this exact pairing.
Inulin passes the small intestine undigested because human enzymes cannot cleave its beta-2,1 linkages, arriving in the colon as fermentable substrate. Pairing a defined strain with a fermentable fibre is the definition of a synbiotic. Note that fermentable fibre also produces gas, and tolerance varies a lot between people.
Established microbial nutrition: inulin is a fructan fermented by lactobacilli and bifidobacteria in the colon.. No combination trial has tested this exact pairing.
Put an earned verification on your own product page.
These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. This record is not medical advice. Always consult your healthcare provider before starting any supplement regimen.